PRESS RELEASE published on 10/26/2023 at 06:55, 1 year ago Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in the nine-month period 2023
PRESS RELEASE published on 10/18/2023 at 16:23, 1 year 1 month ago EQS-Adhoc: Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation
PRESS RELEASE published on 09/14/2023 at 11:08, 1 year 2 months ago Alzchem Group AG: Creatine product 'Creavitalis': Wholesome taste and positive benefits for vegetarian and vegan foods
PRESS RELEASE published on 08/03/2023 at 07:00, 1 year 3 months ago Alzchem Group AG reports positive business development in the first half of 2023
PRESS RELEASE published on 05/12/2023 at 09:04, 1 year 6 months ago Alzchem Group AG ensures continuity on the Management Board: Contract extension with CEO Andreas Niedermaier until 2026
PRESS RELEASE published on 05/11/2023 at 16:53, 1 year 6 months ago Alzchem Group AG: Annual General Meeting resolves increased dividend of EUR 1.05 per share – broad approval of all agenda items, including the climate roadmap
PRESS RELEASE published on 05/04/2023 at 06:55, 1 year 6 months ago Alzchem Group AG achieves significant sales and earnings growth in the first quarter of 2023
PRESS RELEASE published on 02/28/2023 at 07:00, 1 year 8 months ago Alzchem Group AG: Alzchem Group AG achieves highest sales in the company’s history in the fiscal year 2022 with EUR 542.2 million (+28.4%)
Published on 11/21/2024 at 13:30, 38 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 38 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 33 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 53 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 10 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 48 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 23 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 23 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
